Cargando…

Pretreatment [(18)F]FDG PET/CT Prognostic Factors in Patients with Squamous Cell Cervical Carcinoma FIGO IIIC1

Purpose: This study aims to determine whether semiquantitative parameters obtained from both the primary tumor and metastatic pelvic lymph nodes (PLN) diagnosed in fluoro-18-deoxy-glucose positron emission tomography (FDG-PET-CT) are associated with disease-free survival (DFS), local control (LC), d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burchardt, Ewa, Burchardt, Wojciech, Cegła, Paulina, Kubiak, Anna, Roszak, Andrzej, Cholewiński, Witold
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073234/ https://www.ncbi.nlm.nih.gov/pubmed/33923621 http://dx.doi.org/10.3390/diagnostics11040714

Ejemplares similares

Differences between [(18)F]FLT and [(18)F]FDG Uptake in PET/CT Imaging in CC Depend on Vaginal Bacteriology
por: Burchardt, Ewa, et al.
Publicado: (2021)

The effect of different segmentation methods on primary tumour metabolic volume assessed in (18)F-FDG-PET/CT in patients with cervical cancer, for radiotherapy planning
por: Cegła, Paulina, et al.
Publicado: (2019)

Prognostic Value of Pretherapeutic Primary Tumor MTV from [(18)F]FDG PET in Radically Treated Cervical Cancer Patients
por: Cegla, Paulina, et al.
Publicado: (2021)

Asphericity derived from [(18)F]FDG PET as a new prognostic parameter in cervical cancer patients
por: Cegla, Paulina, et al.
Publicado: (2023)

Value of [(18)F]FDG PET/CT radiomic parameters in the context of response to chemotherapy in advanced cervical cancer
por: Burchardt, Ewa, et al.
Publicado: (2023)

Influence of Semiquantitative [(18)F]FDG PET and Hematological Parameters on Survival in HNSCC Patients Using Neural Network Analysis
por: Cegla, Paulina, et al.
Publicado: (2022)

Potential use of [(18)F]FDG heterogeneity in discrimination of two different synchronous primary tumors
por: Cegla, Paulina, et al.
Publicado: (2023)

Sequential delayed [18 F]FDG PET/CT examinations in the pharynx
por: Pietrzak, Agata Karolina, et al.
Publicado: (2020)

The utility of (18)F-FDG PET/CT in brain tumours diagnosis
por: Pietrzak, Agata, et al.
Publicado: (2022)

The quality-adjusted life-years in the oncological patients’ health-related quality of life
por: Kucnerowicz, Karolina, et al.
Publicado: (2022)

Author Correction: The quality-adjusted life-years in the oncological patients’ health-related quality of life
por: Kucnerowicz, Karolina, et al.
Publicado: (2022)

Tumour-Related Parameters as a Prognostic Factor in Patients with Advanced Cervical Cancer: 20-Year Follow-Up of Diagnostic and Treatment Changes during Chemioradiotherapy
por: Warenczak-Florczak, Zaneta, et al.
Publicado: (2022)

Detection of clinically silent brain lesions in [18F]FDG PET/CT study in oncological patients: analysis of over 10,000 studies
por: Pietrzak, Agata, et al.
Publicado: (2021)

Predicting tumor response and outcome of second-look surgery with (18)F-FDG PET/CT: insights from the GINECO CHIVA phase II trial of neoadjuvant chemotherapy plus nintedanib in stage IIIc-IV FIGO ovarian cancer
por: Aide, Nicolas, et al.
Publicado: (2020)

Parametrial involvement and decreased survival of women with FIGO stage IIIC1 cervical cancer
por: Chang, Hong, et al.
Publicado: (2023)

Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors
por: Ye, Yanna, et al.
Publicado: (2023)

Differences between TNM classification and 2-[(18)F]FDG PET parameters of primary tumor in NSCLC patients
por: Cegla, Paulina, et al.
Publicado: (2021)

Primary and Metastatic Brain Tumours Assessed with the Brain and Torso [(18)F]FDG PET/CT Study Protocol—10 Years of Single-Institutional Experiences
por: Pietrzak, Agata, et al.
Publicado: (2021)

Treatment Strategies and Prognostic Factors of 2018 FIGO Stage IIIC Cervical Cancer: A Review
por: Qin, Fengying, et al.
Publicado: (2022)

Validation of the 2018 FIGO Staging System for Predicting the Prognosis of Patients With Stage IIIC Cervical Cancer
por: Long, Xingtao, et al.
Publicado: (2023)

Diagnostic Value of (18)F-FDG PET/MRI for Revised 2018 FIGO Staging in Patients with Cervical Cancer
por: Tsuyoshi, Hideaki, et al.
Publicado: (2021)

Prognostic value of pretreatment (18)F-FDG PET-CT for nasopharyngeal carcinoma patients
por: Huang, Yecai, et al.
Publicado: (2017)

A Risk Stratification for Patients with Cervical Cancer in Stage IIIC1 of the 2018 FIGO Staging System
por: Liu, Xiaoliang, et al.
Publicado: (2020)

Discussion on the rationality of FIGO 2018 stage IIIC for cervical cancer with oncological outcomes: a cohort study
por: Li, Zhiqiang, et al.
Publicado: (2022)

(18)F-FDG-PET/CT-guided intensity-modulated radiotherapy for 42 FIGO III/IV ovarian cancer: A retrospective study
por: Dang, Ya-Zheng, et al.
Publicado: (2019)

Prognostic value of pretreatment (18)F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma
por: Jo, In Young, et al.
Publicado: (2015)

Hypoxic isolated abdominal perfusion breaks through chemoresistance in recurrent FIGO stage IIIC and IV ovarian cancer
por: Aigner, Karl R., et al.
Publicado: (2021)

Image-guided intensity-modulated radiotherapy in patients with FIGO IIIC1 cervical cancer: efficacy, toxicity and prognosis
por: Meng, Qingyu, et al.
Publicado: (2023)

Rationality of FIGO 2018 IIIC restaging of cervical cancer according to local tumor size: A cohort study
por: Duan, Hui, et al.
Publicado: (2023)

Differences among [(18)F]FDG PET-derived parameters in lung cancer produced by three software packages
por: Bos-Liedke, Agnieszka, et al.
Publicado: (2021)

Prognostic Impact of Pretreatment 2-[(18)F]-FDG PET/CT Parameters in Primary Gastric DLBCL
por: Albano, Domenico, et al.
Publicado: (2021)

Prognostic Value of Residual Disease after Interval Debulking Surgery for FIGO Stage IIIC and IV Epithelial Ovarian Cancer
por: Rutten, Marianne J., et al.
Publicado: (2015)

Superficial high-dose-rate brachytherapy for primary tumors and relapses after surgery in patients with basal cell carcinoma of the head and neck region: results of a retrospective comparative cohort study
por: Chyrek, Artur J., et al.
Publicado: (2022)

Reducing dysphagia with palliative 2D high-dose-rate brachytherapy improves survival in esophageal cancer
por: Burchardt, Wojciech, et al.
Publicado: (2019)

Impact of pretreatment second look (18)FDG-PET/CT on stage and treatment changes in head and neck cancer
por: Elicin, Olgun, et al.
Publicado: (2021)

The prognostic value of (18)F-FDG PET/CT intra-tumoural metabolic heterogeneity in pretreatment neuroblastoma patients
por: Liu, Jun, et al.
Publicado: (2022)

Role of (18)F-FDG PET-CT in head and neck squamous cell carcinoma
por: CASTALDI, P., et al.
Publicado: (2013)

Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc
por: Kuhn, W, et al.
Publicado: (1999)

Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer
por: Huang, Chen-Yu, et al.
Publicado: (2020)

Comparison of Postoperative Adjuvant Chemotherapy and Concurrent Chemoradiotherapy for FIGO2018 Stage IIIC1 Cervical Cancer: A Retrospective Study
por: Kagabu, Masahiro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_524ek70g08foecvc5bbrh974gc